The ResApp (ASX:RAP) share price is soaring 10% today. Here's why.

The ResApp Health Ltd (ASX: RAP) share price has soared today after a positive announcement on a new partnership deal.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ResApp Health Ltd (ASX: RAP) share price has surged today following a positive announcement on a partnership agreement.

At the time of writing, shares in the digital health company are 10% higher at 11 cents. This compares to the All Ordinaries Index (ASX: XAO) which is flat at 6,399 points.

a woman

New partnership

ResApp advised it has signed a 12-month marketing agreement with Australia's largest consumer healthcare network, HealthEngine. The new partnership will see HealthEngine integrate its booking network into ResApp's mobile medical application, SleepCheck.

The easy to use, direct-to-consumer mobile application assesses a person's risk of obstructive sleep apnoea by analysing breathing and snoring. It requires no accessories or hardware other than the user's smartphone to make an assessment.

If SleepCheck identifies a person is at risk of obstructive sleep apnoea, the application will direct them to see a doctor. HealthEngine's integration helps patients find and connect with healthcare service providers through a dedicated landing page.

Under the agreement, ResApp will retain all revenues generated from the app download. In addition, for every new patient referred through the Sleep Check application, ResApp will received a portion of the revenue.

Both companies did not state any forecasted earnings as the partnership is in its early stages. However, ResApp was confident of a significant consumer uptake in SleepCheck, unlocking a new revenue stream.

The new partnership has the flexibility to be extended beyond the 12-month agreement.

What did management say?

ResApp CEO and managing director Tony Keating welcomed the collaboration, saying:

This partnership is a tremendous achievement for ResApp and highlights SleepCheck's potential in the Australian market. The agreement with HealthEngine provides us with access to a trusted and reliable consumer healthcare network, which will further improve our offering by allowing users to immediately progress the treatment journey.

This agreement is further evidence of ResApp's ability to attract large, industry leading partners that it can leverage to drive growth well into the future. The company has a number of partnerships pending, which will provide it with a solid foundation to scale.

ResApp share price summary

Despite the uplift in its share price today, ResApp shares have been on a downhill trend for a rolling 52 weeks. Reaching a low of 5.5 cents in March, the ResApp share price has somewhat recovered, up 100%. But the numbers are still a long way off its share price high of 41.5 cents achieved this time last year.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Five young people sit in a row having fun and interacting with their mobile phones.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Wednesday that left investors wanting today.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Opinions

With cash profits jumping to $11 billion, are CBA shares now a buy, hold or sell?

CBA enjoyed a very profitable FY 2026. But is the ASX 200 bank stock a buy for FY 2027?

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Up 73%! 3 reasons I'd still buy Mineral Resources shares today

A leading expert forecasts more outperformance from Mineral Resources' surging shares.

Read more »

Friends in a 4WD.
Broker Notes

Following its results, Macquarie is tipping 80% upside for this ASX 300 stock

This parts supplier appears primed for share price growth.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news.
ASX Share Market News

Why CBA, Seek, and AGL shares are turning heads on Wednesday

Investors are rushing to sell up one of these stocks.

Read more »

Man looks shocked as he works on laptop on top a skyscraper with stockmarket figures in graphic behind him.
ASX Share Market News

Imagine the ASX 200 near-tripling in a year. That's what the KOSPI did in FY26

Then came last month's 44% crash. Here's the full story behind the KOSPI's boom and bust.

Read more »

Happy mum and dad with daughter smiling on couch after relocation to new home.
Broker Notes

After crashing 19% this broker says Life360 shares are a buy

Investors should consider buying the dip after yesterday's sell-off.

Read more »

A white and black clock face is shown with Time to Buy written.
Opinions

2 top ASX shares to buy and hold for the next decade

These stocks have a lot to offer long-term investors…

Read more »